GEN Exclusives

More »

GEN News Highlights

More »
Nov 20, 2007

Rosetta and NYU Expand Collaboration to Include Heart Disease

  • Rosetta Genomics extended an existing collaboration with NYU School of Medicine to include research into congenital heart disease (CHD). Investigators will be screening for specific miRNA biomarkers and signatures that may be used to diagnose and target CHD in newborns.

    "It is now clear that miRNAs play a key role in controlling diverse aspects of cardiac development and response to disease," notes David B. Meyer, M.D., director of pediatric and congenital cardiothoracic surgery at NYU School of Medicine. "Rosetta Genomics' extensive knowledge and proprietary technologies in the miRNA field, coupled with our experience in CHD, is an excellent starting point for this collaboration."



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?